ArticleThe Journal of infectious diseases2026
Corticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case Series.
Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundPost-infectious inflammatory response syndrome (PIIRS) is recognized as a cause of neurologic deterioration in previously healthy patients with cryptococcal meningoencephalitis (CM). However, data on non-human immunodeficiency virus (HIV), immunosuppressed patients remain limited.
methodsBetween July 2018 and April 2025, 13 non-HIV immunosuppressed patients with CM who subsequently developed PIIRS were included. Clinical features, Karnofsky performance scores, cerebrospinal fluid (CSF) parameters, and magnetic resonance imaging (MRI) findings were compared at PIIRS diagnosis and during follow-up after corticosteroid therapy.
resultsAll patients showed evidence of CNS inflammation, including abnormal CSF, MRI findings, and neurological symptoms such as altered mental status or visual/hearing loss. Corticosteroid therapy was associated with significant improvements in Karnofsky scores at 1 month (P = .001), with sustained benefit at 6 and twelve months (P = .002); all 10 surviving patients demonstrated resolution of neurological symptoms. CSF inflammatory parameters including white blood cell (WBC) count, protein, and CSF/serum glucose ratio also significantly improved at 1 month. Brain MRI findings also showed a trend toward improvement. All patients remained culture-negative post-PIIRS diagnosis. Three patients died: 1 from complications of alcoholic cirrhosis, the second from liver failure in the setting of systemic lupus erythematosus and immunosuppression, and the third from sepsis after initiation of corticosteroids.
conclusionsCorticosteroids were associated with improvement in neurological status and neuroinflammation in non-HIV, immunosuppressed patients with PIIRS following CM. These findings support its potential role as salvage therapy in this population and highlight the need for systematic data collection or randomized trials to better guide corticosteroid use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.